Article Figures & Data
Tables
- Table 1:
Baseline clinical and radiographic characteristics of patients based on prior statin treatment
Baseline Characteristics Prior Statin (n = 96) No Prior Statin (n = 322) P Value Age (yr) (median) (IQR) 73 (14) 66 (24) <.001 Sex (% male) 68% (65/96) 58% (187/322) .09 Smoking 15% (14/96) 15% (49/322) .87 Hypertension (%) 73% (70/96) 50% (159/322) <.001 Diabetes mellitus (%) 19% (18/96) 12% (39/322) .044 Prior ASA treatment (%) 65% (62/96) 22% (71/322) <.001 Symptomatic carotid diseasea 19% (18/96) 7% (21/322) .001 Symptomatic intracranial diseaseb 12% (11/96) 21% (67/322) .174 Positive CTA findingc 31% (30/96) 27% (88/322) .45 DWI-positive 64% (61/96) 55% (177/322) .08 DWI infarct volume (mL) (median) (IQR) 1.0 (2.5) 1.1 (4) .56 - Table 2:
Baseline clinical and radiographic characteristics stratified by statin treatment (statin therapy either continued or acutely started) or not
Baseline Characteristics On Statin Treatmenta (n = 251) No Statin Treatment (n = 167) P Value Age (yr) (median) (IQR) 70 (18) 62 (25) <.001 Hypertension (%) 63% (159/251) 42% (70/167) <.001 Sex (% male) 65% (163/251) 53% (89/167) .01 Smoking 17% (42/251) 13% (21/167) .24 Diabetes mellitus (%) 15% (38/251) 11% (19/167) .38 Symptomatic extracranial carotid disease ≥50% (%) 13% (33/251) 4% (6/167) .001 Symptomatic intracranial vascular occlusion/stenosis ≥50% (%) 25% (63/251) 15% (25/167) .013 Positive CTA findingb 36% (89/251) 17% (29/167) <.001 DWI-positive on baseline MRI 69% (172/251) 40% (66/167) <.001 DWI infarct volume (mL) (median) (IQR) 1.1 (3.8) 1.0 (2.9) .48